JENNIFER BRECK: Open Payments
NPI 1821742735 · MODESTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,000 in 17 payments from 5 companies in 2025. Trend: 2023 $125 · 2024 $357 · 2025 $1,000
Food & beverage: $1,000
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $407 |
| Novo Nordisk Inc | 4 | $344 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $144 |
| GlaxoSmithKline, LLC. | 5 | $81 |
| ABIOMED | 1 | $23 |
Products named: Wegovy, TEZSPIRE, AIRSUPRA, XIFAXAN, Ozempic, TRELEGY ELLIPTA, RELISTOR, Rybelsus.
Industry payments across CA — which companies pay providers there.
